Search clinical trials for: Solifenacin Succinate Formulation B
Total 290 results
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin Succinate | Bioavailability of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveSweden, United Kingdom, Belgium, Denmark
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Center Eugene MarquisTerminated
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Stamford HospitalWithdrawnOveractive Bladder | Urge Incontinence | Urinary UrgeUnited States
-
Beni-Suef UniversityCompletedVoiding DisordersEgypt
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityUnited States, Belgium, Brazil, Denmark, Hungary, Korea, Republic of, Mexico, Philippines, Poland, Turkey
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
University of South FloridaWithdrawnUrinary Incontinence | Parkinson's DiseaseUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Greece, Russian Federation, Czech Republic, Poland, Hungary, Italy, Slovakia, Egypt
-
Astellas Pharma Europe Ltd.CompletedOveractive Bladder (OAB) | Lower Urinary Tract Symptoms (LUTS)Ireland
-
University of South FloridaCompletedOveractive Bladder in Parkinson's DiseaseUnited States
-
Astellas Pharma IncCompletedUrinary IncontinenceUnited States, Canada
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Advanced Research NetworkAstellas Pharma US, Inc.TerminatedOver-Active BladderUnited States
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveUnited States
-
Astellas Pharma Europe B.V.Completed
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
Dong-A ST Co., Ltd.Active, not recruitingOveractive BladderKorea, Republic of
-
Shanghai University of Traditional Chinese MedicineLonghua HospitalRecruitingOveractive BladderChina
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, United States, Brazil, Canada, Denmark, Former Serbia and Montenegro, Korea, Republic of, Mexico, Norway, Philippines, Poland, South Africa, Sweden, Turkey, Ukraine, United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Urinary Incontinence | Urge IncontinenceFrance, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveFrance, United Kingdom, Spain, Belarus, Belgium, Ukraine, Denmark, Greece, Russian Federation, Czech Republic, Netherlands, Germany, Hungary, Italy, Slovakia, Sweden, Norway
-
Dong-A ST Co., Ltd.CompletedOveractive BladderKorea, Republic of
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
Genuine Research Center, EgyptHikma PharmaCompleted
-
Rambam Health Care CampusUnknownUrinary Bladder, OveractiveIsrael
-
Peking Union Medical College HospitalAstellas Pharma China, Inc.; Beijing CAT Science Co., Ltd.CompletedOveractive Bladder | Urination Disorders | Postmenopausal DisorderChina
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina
-
GlaxoSmithKlineCompletedMultiple SclerosisPoland, Germany, Czechia
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Astellas Pharma IncAstellas Pharma Korea, Inc.CompletedOver Active BladderKorea, Republic of
-
Seattle Urology Research CenterUnknownNocturia | Urinary Urgency | Urinary FrequencyUnited States
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Timothy Boone, MD, PhDAstellas Pharma US, Inc.CompletedLower Urinary Tract SymptomsUnited States
-
Lahey ClinicAstellas Pharma US, Inc.TerminatedOveractive BladderUnited States
-
Loyola UniversityAstellas Pharma US, Inc.CompletedUrge Urinary IncontinenceUnited States
-
Medicines for Malaria VentureRichmond Pharmacology LimitedCompleted
-
Idorsia Pharmaceuticals Ltd.Completed
-
Lyndra Inc.CompletedHealthy | Gastric RetentionAustralia
-
National Taiwan University HospitalUnknown
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
Far Eastern Memorial HospitalCompletedOveractive BladderTaiwan
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Poland, Slovakia, Belarus, Germany, Czechia
-
National Taiwan University HospitalUnknownOveractive Bladder SyndromeTaiwan